NCT01847144 MASTERMIND - Understanding Individual Variation in Treatment Response in Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT01845831 Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT01843387 Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy Status COMPLETED Phase PHASE1/PHASE2
NCT01841697 Study to Evaluate the Safety and Efficacy of the Addition of Omarigliptin (MK-3102) Compared With the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026) Status COMPLETED Phase PHASE3
NCT01839448 Abnormal Post-partum Glucose Metabolism After Gestational Diabetes Diagnosed Before or After 24 Weeks of Gestation Status COMPLETED Phase N/A
NCT01836796 Metabolic Effects of Lactobacillus Reuteri DSM 17938 in Type 2 Diabetes Status COMPLETED Phase NA
NCT01832181 MiTy Kids (Metformin in Women With Type 2 Diabetes in Pregnancy Kids Trial) Status COMPLETED Phase N/A
NCT01822548 Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01820273 Changes in Incretins Response and Glycemic Control After Gastric Bypass Surgery in Type 2 Diabetic Patients Versus Healthy Status WITHDRAWN Phase N/A
NCT01817569 Specific Clinical Experience Investigation for Long-term Use of Exenatide (Byetta Subcutaneous Injection) Status COMPLETED Phase N/A
NCT01814787 Computer Automation for Diagnosis and Management of Childhood Type 2 Diabetes Status COMPLETED Phase NA